As cancer survival rates improve, cardiovascular complications have become a major concern. At the Heart World Conference (HWC) 2026, this session will explore the intersection of oncology and cardiology, highlighting strategies to detect, manage, and prevent heart disease in cancer patients and survivors exposed to cardiotoxic therapies.